State Street’s OncoSec Medical Incorporated ONCS Stock Holding History

State Street’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,187	Closed	-$65K	–	4839
2023 Q1	$65K	Hold	25,187	–	–	﹤0.01%	4437
2022 Q4	$42.3K	Buy	25,187 +23,199	+1,167%	+$130K	﹤0.01%	4593
2022 Q3	$21K	Hold	1,988	–	–	﹤0.01%	4831
2022 Q2	$32K	Hold	1,988	–	–	﹤0.01%	4810
2022 Q1	$50K	Hold	1,988	–	–	﹤0.01%	4796
2021 Q4	$42K	Hold	1,988	–	–	﹤0.01%	4723
2021 Q3	$93K	Buy	1,988 +1,082	+119%	+$54.8K	﹤0.01%	4568
2021 Q2	$56K	Buy	+906	New	+$82.2K	﹤0.01%	4422
2019 Q2	–	Sell	-60	Closed	-$7K	–	3886
2019 Q1	$7K	Hold	60	–	–	﹤0.01%	3736
2018 Q4	$9K	Hold	60	–	–	﹤0.01%	3742
2018 Q3	$19K	Hold	60	–	–	﹤0.01%	3739
2018 Q2	$18K	Hold	60	–	–	﹤0.01%	3738
2018 Q1	$25K	Buy	+60	New	+$24.6K	﹤0.01%	3707

State Street's ONCS Position: Q2 2023 in Review

State Street sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 25,187 shares — an estimated $65K sold.

State Street first reported a position in ONCS in Q1 2018 and held it in 13 quarters. The position peaked at $93K in Q3 2021. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.

State Street reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
State Street sold 25,187 OncoSec Medical Incorporated shares in Q2 2023, an estimated $65K.
State Street first reported a position in OncoSec Medical Incorporated in Q1 2018 and held it in 13 quarters.
State Street's OncoSec Medical Incorporated position peaked at $93K in Q3 2021.
0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.